The aspirin primary prevention conundrum

Miri Schamroth Pravda*, Nili Schamroth Pravda, Yitzhak Beigel, Shlomi Matetzky, Roy Beigel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


In this review, the authors re-examine the role of aspirin in the primary prevention of cardiovascular disease. They discuss the history of the use of aspirin in primary prevention, the current guidelines, and the recent evidence surrounding aspirin use as primary prevention in special populations such as those with moderate cardiovascular risk, diabetes mellitus, and the elderly.

Original languageEnglish
Pages (from-to)60-63
Number of pages4
JournalIsrael Medical Association Journal
Issue number1
StatePublished - 2020


  • Aspirin
  • Cardiovascular disease
  • Primary prevention


Dive into the research topics of 'The aspirin primary prevention conundrum'. Together they form a unique fingerprint.

Cite this